IMV Inc. Made Big Gain

Thu, Dec 15, 2022 at 06:58 PM

IMV Inc. (IMV:NASDAQ) shot up at $3.64, a gain of 66.6%. On Thu, Dec 15, 2022, IMV:NASDAQ touched a New 2-Week High of $3.64. The stock appeared on our News Catalysts scanner on Thu, Dec 15, 2022 at 08:04 AM in the 'BIOTECH' category. From Thu, Dec 01, 2022, the stock recorded 50.00% Up Days and 54.55% Green Days

About IMV Inc. (IMV:NASDAQ)

Immunovaccine Inc is a Canada based clinical-stage biopharmaceutical company. Through its subsidiary, the firm develops T cell activating cancer immunotherapies and infectious disease vaccines based on DepoVax.

Top 10 Gainers:

Larkspur Health Acquisition Corp. (LSPR:NASDAQ), 132.68%
Core Scientific Inc Cl A (CORZ:NASDAQ), 72%
IMV Inc. (IMV:NASDAQ), 66.55%
Creatd Inc. (CRTD:NASDAQ), 57.76%
Scopus BioPharma Inc. (SCPS:NASDAQ), 44.85%
BeyondSpring Inc. (BYSI:NASDAQ), 33.04%
Hoth Therapeutics, Inc. (HOTH:NASDAQ), 31.13%
Nuvve Holding Corp. (NVVE:NASDAQ), 31.05%
Landos Biopharma Inc. (LABP:NASDAQ), 30.46%
NewAmsterdam Pharma Company N.V. (NAMS:NASDAQ), 27.66%